cyanidin 3-O-beta-D-glucoside, cyanidin 3-O-glucoside, cyanidin-3,5-diglucoside, cyanidin-3-glucoside, cyanidin-3-O-beta-glucopyranoside, cyanidin-3-O-beta-glucoside

| Name | Kuromanin chloride | ||
| PubChem CID | 197081 | ||
| Molecular Weight | 484.8g/mol | ||
| Synonyms |
cyanidin 3-O-beta-D-glucoside, cyanidin 3-O-glucoside, cyanidin-3,5-diglucoside, cyanidin-3-glucoside, cyanidin-3-O-beta-glucopyranoside, cyanidin-3-O-beta-glucoside |
||
| Formula | C₂₁H₂₁ClO₁₁ | ||
| SMILES | C1=CC(=C(C=C1C2=[O+]C3=CC(=CC(=C3C=C2OC4C(C(C(C(O4)CO)O)O)O)O)O)O)O.[Cl-] | ||
| InChI | 1S/C21H20O11.ClH/c22-7-16-17(27)18(28)19(29)21(32-16)31-15-6-10-12(25)4-9(23)5-14(10)30-20(15)8-1-2-11(24)13(26)3-8;/h1-6,16-19,21-22,27-29H,7H2,(H3-,23,24,25,26);1H/t16-,17-,18+,19-,21-;/m1./s1 | ||
| InChIKey | YTMNONATNXDQJF-UBNZBFALSA-N | ||
| CAS Number | 7084-24-4 | ||
| Toxicity | Organism | Test Type | Route(Dose) |
| rat | LD50 | intraperitoneal(165 mg/kg) | |
| mouse | LD50 | intraperitoneal(254 mg/kg) | |
| rat | LD50 | oral(322 mg/kg) | |
| Structure |
Download
2D
MOL
3D
MOL
|
||
| Chineses Pinyin | DiYu | ||
| Use Part | Root | ||
| Habitat | Shaanxi, GanSu, QingHai, NingXia, XinJiang, HeiLongJiang, JiLin, LiaoNing | ||
| Flavor | Bitter, Sour, Astringent | ||
| Meridian Tropism | Liver, Large intestine | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Rosales
-->Family: Rosaceae
-->Genus: Sanguisorba
-->Species: Sanguisorba officinalis
|
||
| Chineses Pinyin | Sang | ||
| Use Part | Leaf; Root; Branche; Fruit | ||
| Habitat | China | ||
| Flavor | Sweet | ||
| Meridian Tropism | Lung | ||
| Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Rosales
-->Family: Moraceae
-->Genus: Morus
-->Species: Morus alba
|
||
| Pair Name | Kuromanin chloride, Cisplatin | |||
| Partner Name | Cisplatin | |||
| Disease Info | [ICD-11: 2C77.Z] | Cervical cancer | Investigative | |
| Biological Phenomena | Induction-->Apoptosis | |||
| Gene Regulation | Up-regulation | Expression | BAX | hsa581 |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Down-regulation | Expression | GABPA | hsa2551 | |
| In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
| Result | These results expanded our understanding of the role of C3G in a cervical cancer cell model, and provided a potential new treatment strategy for this cancer, as well as a theoretical basis for the development of new drugs in the future. | |||
| Pair Name | Kuromanin chloride, Cisplatin | |||
| Partner Name | Cisplatin | |||
| Disease Info | [ICD-11: 2C77.Z] | Cervical cancer | Investigative | |
| Biological Phenomena | Induction-->Blockade of cell cycle in G0/G1 phase | |||
| Gene Regulation | Down-regulation | Expression | CCND1 | hsa595 |
| Down-regulation | Expression | BCL2 | hsa596 | |
| Up-regulation | Activity | BAX | hsa581 | |
| Up-regulation | Cleavage | CASP3 | hsa836 | |
| Up-regulation | Activity | TP53 | hsa7157 | |
| Up-regulation | Activity | TIMP1 | hsa7076 | |
| Down-regulation | Expression | PIK3CA | hsa5290 | |
| Down-regulation | Expression | AKT1 | hsa207 | |
| Down-regulation | Expression | MTOR | hsa2475 | |
| In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
| Result | Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells | |||
| No. | Title | Href |
|---|---|---|
| 1 | Cyanidin-3-O-glucoside and cisplatin inhibit proliferation and downregulate the PI3K/AKT/mTOR pathway in cervical cancer cells. J Food Sci. 2021 Jun;86(6):2700-2712. doi: 10.1111/1750-3841.15740. | Click |
| 2 | Combination of cyanidin-3-O-glucoside and cisplatin induces oxidative stress and apoptosis in HeLa cells by reducing activity of endogenous antioxidants, increasing bax/bcl-2 mRNA expression ratio, and downregulating Nrf2 expression. J Food Biochem. 2021 Jul;45(7):e13806. doi: 10.1111/jfbc.13806. | Click |